Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TDP-43 inhibitory peptide alleviates neurodegeneration and memory loss in an APP transgenic mouse model for Alzheimer's disease

2 Nov 2019

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to GDF15 and Related Biomarkers
Share to Tryptophan and brain disorders

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 31678156
DOI: 10.1016/j.bbadis.2019.165580

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TDP-43 inhibitory peptide alleviates neurodegeneration and memory loss in an APP transgenic mouse model for Alzheimer's diseasePMID 31678156Read ↗

The Role of TDP-43 in Alzheimer’s DiseaseSemantic proximity Read ↗

The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic miceSemantic proximity Read ↗

Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's diseaseSemantic proximity Read ↗

TDP-43 Pathology in Alzheimer’s DiseaseSemantic proximity Read ↗

APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis.Semantic proximity Read ↗

Tau-Targeting Nanoparticles for Treatment of Alzheimer's DiseaseSemantic proximity Read ↗

NVP-BEZ235 enhances autophagy and ameliorates cognitive deficits by targeting tauopathiesSemantic proximity Read ↗

TDP-43: an emerging new player in neurodegenerative diseasesSemantic proximity Read ↗

Peptides alleviate cognitive impairment by inhibiting and disassembling amyloid-β aggregates in Alzheimer’s diseaseSemantic proximity Read ↗

Suvorexant ameliorates cognitive impairments and pathology in APP/PS1 transgenic miceSemantic proximity Read ↗

Targeting Alzheimer's disease with gene and cell therapiesSemantic proximity Read ↗

Targeting MicroRNA-485-3p Blocks Alzheimer’s Disease ProgressionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.